Insider Transactions in Q4 2021 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Dwight Gary Gilliland Director |
SELL
Open market or private sale
|
Direct |
500
-1.88%
|
$151,000
$302.28 P/Share
|
|
Dec 14
2021
|
Kerrii B Anderson Director |
SELL
Bona fide gift
|
Direct |
1,550
-2.6%
|
-
|
|
Nov 05
2021
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-12.59%
|
$246,326
$274.84 P/Share
|
|
Nov 05
2021
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+21.97%
|
-
|
|
Nov 05
2021
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-8.92%
|
$246,326
$274.84 P/Share
|
|
Nov 05
2021
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+16.63%
|
-
|
|
Nov 01
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct |
898
-9.12%
|
$258,624
$288.78 P/Share
|
|
Nov 01
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,007
+16.93%
|
-
|
|
Nov 01
2021
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,034
-8.68%
|
$1,161,792
$288.78 P/Share
|
|
Nov 01
2021
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,024
+16.27%
|
-
|
|
Nov 01
2021
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
886
-6.66%
|
$255,168
$288.78 P/Share
|
|
Nov 01
2021
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,007
+13.12%
|
-
|